Charter Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$305K Sell
2,374
-2
-0.1% -$234 0.14% 56
2026
Q1
$286K Buy
2,376
+1
+0% +$115 0.14% 54
2025
Q4
$250K Sell
2,375
-15
-0.6% -$1.41K 0.13% 55
2025
Q3
$201K Buy
+2,390
New +$197K 0.11% 61

Other funds holding MRK

Charter Capital Management's MRK Position: Q2 2026 in Review

Charter Capital Management reduced its Merck (MRK) stake by 0.08% in Q2 2026, selling an estimated $234 and leaving 2,374 shares worth $305K. The position accounts for 0.14% of the portfolio, ranked #56.

Charter Capital Management first reported a position in MRK in Q3 2025 and has held it in 4 quarters since. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Charter Capital Management held 2,374 shares of Merck worth $305K as of Q2 2026.
  • Charter Capital Management sold 2 Merck shares in Q2 2026, an estimated $234.
  • Merck made up 0.14% of Charter Capital Management's portfolio in Q2 2026, its #56 holding.
  • Charter Capital Management first reported a position in Merck in Q3 2025 and has held it in 4 quarters since.
  • 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Charter Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.